{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:22:55Z","timestamp":1787008975111,"version":"build-2736575974"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"ERDF","doi-asserted-by":"publisher","award":["2017\/085"],"award-info":[{"award-number":["2017\/085"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010805","name":"Fundaci\u00f3n Tatiana P\u00e9rez de Guzm\u00e1n el Bueno","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010774","name":"Consejer\u00eda de Educaci\u00f3n e Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PEJD-2018-PRE\/BMD-7899"],"award-info":[{"award-number":["PEJD-2018-PRE\/BMD-7899"]}],"id":[{"id":"10.13039\/501100010774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014365","name":"Instituto de investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n","doi-asserted-by":"publisher","award":["PEJ15\/BIO\/TL-0216"],"award-info":[{"award-number":["PEJ15\/BIO\/TL-0216"]}],"id":[{"id":"10.13039\/501100014365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"CIBERSAM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"Fondo Europeo de Desarrollo Regional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","award":["PI18\/01691"],"award-info":[{"award-number":["PI18\/01691"]}],"id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","award":["2019I041"],"award-info":[{"award-number":["2019I041"]}],"id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","award":["PI-0080-2017"],"award-info":[{"award-number":["PI-0080-2017"]}],"id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","award":["PI-0009-2017"],"award-info":[{"award-number":["PI-0009-2017"]}],"id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consejer\u00eda de Salud de la Junta de Andaluc\u00eda","award":["PI-0134-2018"],"award-info":[{"award-number":["PI-0134-2018"]}]},{"DOI":"10.13039\/501100008723","name":"University of C\u00e1diz","doi-asserted-by":"publisher","award":["PR2019-046"],"award-info":[{"award-number":["PR2019-046"]}],"id":[{"id":"10.13039\/501100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Ciencias Biom\u00e9dicas de C\u00e1diz","award":["IN-C22"],"award-info":[{"award-number":["IN-C22"]}]},{"name":"Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Ciencias Biom\u00e9dicas de C\u00e1diz","award":["LI19\/06IN-CO22"],"award-info":[{"award-number":["LI19\/06IN-CO22"]}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo de la Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-510"],"award-info":[{"award-number":["CTS-510"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo de la Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CB\/07\/09\/0033"],"award-info":[{"award-number":["CB\/07\/09\/0033"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["SAM16PE07CP1"],"award-info":[{"award-number":["SAM16PE07CP1"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/02012"],"award-info":[{"award-number":["PI16\/02012"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/024"],"award-info":[{"award-number":["PI19\/024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Minocycline (MIN) is a tetracycline with antioxidant, anti-inflammatory, and neuroprotective properties. Given the likely involvement of inflammation and oxidative stress (IOS) in schizophrenia, MIN has been proposed as a potential adjuvant treatment in this pathology. We tested an early therapeutic window, during adolescence, as prevention of the schizophrenia-related deficits in the maternal immune stimulation (MIS) animal model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>On gestational day 15, Poly I:C or vehicle was injected in pregnant Wistar rats. A total 93 male offspring received MIN (30 mg\/kg) or saline from postnatal day (PND) 35\u201349. At PND70, rats were submitted to the prepulse inhibition test. FDG-PET and T2-weighted MRI brain studies were performed at adulthood. IOS markers were evaluated in frozen brain tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MIN treatment did not prevent prepulse inhibition test behavioral deficits in MIS offspring. However, MIN prevented morphometric abnormalities in the third ventricle but not in the hippocampus. Additionally, MIN reduced brain metabolism in cerebellum and increased it in nucleus accumbens. Finally, MIN reduced the expression of iNOS (prefrontal cortex, caudate-putamen) and increased the levels of KEAP1 (prefrontal cortex), HO1 and NQO1 (amygdala, hippocampus), and HO1 (caudate-putamen).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MIN treatment during adolescence partially counteracts volumetric abnormalities and IOS deficits in the MIS model, likely via iNOS and Nrf2\u2013ARE pathways, also increasing the expression of cytoprotective enzymes. However, MIN treatment during this peripubertal stage does not prevent sensorimotor gating deficits. Therefore, even though it does not prevent all the MIS-derived abnormalities evaluated, our results suggest the potential utility of early treatment with MIN in other schizophrenia domains.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyab036","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T15:13:51Z","timestamp":1624029231000},"page":"734-748","source":"Crossref","is-referenced-by-count":19,"title":["A Characterization of the Effects of Minocycline Treatment During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders"],"prefix":"10.1093","volume":"24","author":[{"given":"Diego","family":"Romero-Miguel","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Casquero-Veiga","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina S","family":"MacDowell","sequence":"additional","affiliation":[{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Torres-Sanchez","sequence":"additional","affiliation":[{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Neuropsychopharmacology and Psychobiology Research Group, Psychobiology Area, Department of Psychology, Universidad de C\u00e1diz, Puerto Real (C\u00e1diz), Spain"},{"name":"Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Ciencias Biom\u00e9dicas de C\u00e1diz, INiBICA, Hospital Universitario Puerta del Mar, C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Garcia-Partida","sequence":"additional","affiliation":[{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Neuropsychopharmacology and Psychobiology Research Group, Psychobiology Area, Department of Psychology, Universidad de C\u00e1diz, Puerto Real (C\u00e1diz), Spain"},{"name":"Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Ciencias Biom\u00e9dicas de C\u00e1diz, INiBICA, Hospital Universitario Puerta del Mar, C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Lamanna-Rama","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Romero-Miranda","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Berrocoso","sequence":"additional","affiliation":[{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Neuropsychopharmacology and Psychobiology Research Group, Psychobiology Area, Department of Psychology, Universidad de C\u00e1diz, Puerto Real (C\u00e1diz), Spain"},{"name":"Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Ciencias Biom\u00e9dicas de C\u00e1diz, INiBICA, Hospital Universitario Puerta del Mar, C\u00e1diz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C","family":"Leza","sequence":"additional","affiliation":[{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense (UCM), IIS Imas12, IUIN, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Desco","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"Departamento de Bioingenier\u00eda e Ingenier\u00eda Aeroespacial, Universidad Carlos III de Madrid, Legan\u00e9s, Spain"},{"name":"Centro Nacional de Investigaciones Cardiovasculares, CNIC, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Soto-Montenegro","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"CIBER de Salud Mental (CIBERSAM), Madrid, Spain"},{"name":"High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorc\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"2021092108144181600_CIT0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmpb.2011.06.008","article-title":"Software architecture for multi-bed FDK-based reconstruction in X-ray CT scanners","volume":"107","author":"Abella","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"2021092108144181600_CIT0002","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines: effects on nitric oxide synthases","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021092108144181600_CIT0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","article-title":"Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs","volume":"27","author":"Andersson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"2021092108144181600_CIT0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pnpbp.2012.06.014","article-title":"Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression","volume":"42","author":"Anderson","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021092108144181600_CIT0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.schbul.a033321","article-title":"\u201cCognitive dysmetria\u201d as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?","volume":"24","author":"Andreasen","year":"1998","journal-title":"Schizophr Bull"},{"key":"2021092108144181600_CIT0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2008.01.003","article-title":"The role of the cerebellum in schizophrenia","volume":"64","author":"Andreasen","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2021092108144181600_CIT0007","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.neuroimage.2004.07.010","article-title":"Geodesic estimation for large deformation anatomical shape averaging and interpolation","volume":"23 Suppl 1","author":"Avants","year":"2004","journal-title":"Neuroimage"},{"key":"2021092108144181600_CIT0008","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/0004867417715914","article-title":"Ventricular volumes across stages of schizophrenia and other psychoses","volume":"51","author":"Berger","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"2021092108144181600_CIT0009","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.expneurol.2016.06.012","article-title":"Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia","volume":"283","author":"Bikovsky","year":"2016","journal-title":"Exp Neurol"},{"key":"2021092108144181600_CIT0010","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"2021092108144181600_CIT0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am J Psychiatry"},{"key":"2021092108144181600_CIT0012","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuroimage.2009.03.021","article-title":"Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization","volume":"46","author":"Borghammer","year":"2009","journal-title":"Neuroimage"},{"key":"2021092108144181600_CIT0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am J Psychiatry"},{"key":"2021092108144181600_CIT0014","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.euroneuro.2019.05.002","article-title":"Risperidone administered during adolescence induced metabolic, anatomical and inflammatory\/oxidative changes in adult brain: a PET and MRI study in the maternal immune stimulation animal model","volume":"29","author":"Casquero-Veiga","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"2021092108144181600_CIT0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.euroneuro.2021.02.001","article-title":"Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: neurophysiological evidences from the prenatal viral infection with PolyI:C","volume":"46","author":"Casquero-Veiga","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"2021092108144181600_CIT0016","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J Psychopharmacol"},{"key":"2021092108144181600_CIT0017","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1590\/S0100-879X2009001100002","article-title":"Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update","volume":"42","author":"Chaves","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"2021092108144181600_CIT0018","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.pnpbp.2010.01.020","article-title":"Functional neuroimaging of minocycline\u2019s effect in a patient with schizophrenia","volume":"34","author":"Chaves","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021092108144181600_CIT0019","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s12311-017-0874-5","article-title":"Cerebellar contributions to persistent auditory verbal hallucinations in patients with schizophrenia","volume":"16","author":"Cierpka","year":"2017","journal-title":"Cerebellum"},{"key":"2021092108144181600_CIT0020","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2016.247","article-title":"Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28","volume":"22","author":"Collste","year":"2017","journal-title":"Mol Psychiatry"},{"key":"2021092108144181600_CIT0021","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12888-019-2318-x","article-title":"Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists","volume":"19","author":"Correll","year":"2019","journal-title":"BMC Psychiatry"},{"key":"2021092108144181600_CIT0022","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1038\/tp.2016.40","article-title":"In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma","volume":"6","author":"Coughlin","year":"2016","journal-title":"Transl Psychiatry"},{"key":"2021092108144181600_CIT0023","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2018.06.001","article-title":"Minocycline attenuates brain injury and iron overload after intracerebral hemorrhage in aged female rats","volume":"126","author":"Dai","year":"2019","journal-title":"Neurobiol Dis"},{"key":"2021092108144181600_CIT0024","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0885-4505(87)90035-1","article-title":"Studies on the effects of the narcotic alkaloids, cocaine, morphine, and codeine on nonenzymatic lipid peroxidation in rat brain mitochondria","volume":"37","author":"Das","year":"1987","journal-title":"Biochem Med Metab Biol"},{"key":"2021092108144181600_CIT0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","article-title":"The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Deakin","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2021092108144181600_CIT0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fpsyt.2017.00238","article-title":"Microglia and brain plasticity in acute psychosis and schizophrenia illness course: a meta-review","volume":"8","author":"De Picker","year":"2017","journal-title":"Front Psychiatry"},{"key":"2021092108144181600_CIT0027","doi-asserted-by":"crossref","first-page":"e1225","DOI":"10.1038\/tp.2017.193","article-title":"PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia","volume":"7","author":"Di Biase","year":"2017","journal-title":"Transl Psychiatry"},{"key":"2021092108144181600_CIT0028","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/schbul\/sbaa016","article-title":"Compression of cerebellar functional gradients in schizophrenia","volume":"46","author":"Dong","year":"2020","journal-title":"Schizophr Bull"},{"key":"2021092108144181600_CIT0029","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med"},{"key":"2021092108144181600_CIT0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/npp.2017.183","article-title":"Dopamine transporter and reward anticipation in a dimensional perspective: a multimodal brain imaging study","volume":"43","author":"Dubol","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"2021092108144181600_CIT0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1503\/jpn.090049","article-title":"Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia","volume":"35","author":"Ebdrup","year":"2010","journal-title":"J Psychiatry Neurosci"},{"key":"2021092108144181600_CIT0032","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pnpbp.2007.08.031","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline","volume":"32","author":"Fujita","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021092108144181600_CIT0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2012.10.006","article-title":"What is behind the non-antibiotic properties of minocycline?","volume":"67","author":"Garrido-Mesa","year":"2013","journal-title":"Pharmacol Res"},{"key":"2021092108144181600_CIT0034","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2021092108144181600_CIT0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ijnp\/pyx067","article-title":"Differential patterns of subcortical activity evoked by glial GLT-1 blockade in prelimbic and infralimbic cortex: relationship to antidepressant-like effects in rats","volume":"20","author":"Gasull-Camos","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021092108144181600_CIT0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"2021092108144181600_CIT0037","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1038\/tp.2016.38","article-title":"Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia","volume":"6","author":"Giovanoli","year":"2016","journal-title":"Transl Psychiatry"},{"key":"2021092108144181600_CIT0038","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.schres.2015.05.010","article-title":"Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course","volume":"166","author":"Hadar","year":"2015","journal-title":"Schizophr Res"},{"key":"2021092108144181600_CIT0039","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/mp.2017.52","article-title":"Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia","volume":"23","author":"Hadar","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2021092108144181600_CIT0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4045\/tidsskr.12.1084","article-title":"Schizophrenia\u2013what does structural MRI show?","volume":"133","author":"Haukvik","year":"2013","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2021092108144181600_CIT0041","doi-asserted-by":"crossref","first-page":"e84987","DOI":"10.1371\/journal.pone.0084987","article-title":"Brain metabolism during hallucination-like auditory stimulation in schizophrenia","volume":"9","author":"Horga","year":"2014","journal-title":"PLoS One"},{"key":"2021092108144181600_CIT0042","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pscychresns.2007.12.023","article-title":"Structural abnormalities of the right inferior colliculus in schizophrenia","volume":"164","author":"Kang","year":"2008","journal-title":"Psychiatry Res"},{"key":"2021092108144181600_CIT0043","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/JCP.0000000000000345","article-title":"Adjunctive minocycline in clozapine-treated schizophrenia patients with persistent symptoms","volume":"35","author":"Kelly","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"2021092108144181600_CIT0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/schbul\/sbu157","article-title":"Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA","volume":"41","author":"Kenk","year":"2015","journal-title":"Schizophr Bull"},{"key":"2021092108144181600_CIT0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.psychres.2013.12.051","article-title":"Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study","volume":"215","author":"Khodaie-Ardakani","year":"2014","journal-title":"Psychiatry Res"},{"key":"2021092108144181600_CIT0046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2016.10.020","article-title":"Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: a high-resolution PET study using [11C]DASB and [18F]FDG","volume":"182","author":"Kim","year":"2017","journal-title":"Schizophr Res"},{"key":"2021092108144181600_CIT0047","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-3223(01)01267-7","article-title":"Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia","volume":"50","author":"Konradi","year":"2001","journal-title":"Biol Psychiatry"},{"key":"2021092108144181600_CIT0048","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1089\/ars.2012.4858","article-title":"Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models","volume":"18","author":"Kulak","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"2021092108144181600_CIT0049","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s12035-015-9137-y","article-title":"Minocycline rescues from zinc-induced nigrostriatal dopaminergic neurodegeneration: biochemical and molecular interventions","volume":"53","author":"Kumar","year":"2016","journal-title":"Mol Neurobiol"},{"key":"2021092108144181600_CIT0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1471-4159.2004.02780.x","article-title":"Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS\/NO induction by lipopolysaccharide in neuron\/glia co-cultures","volume":"91","author":"Lee","year":"2004","journal-title":"J Neurochem"},{"key":"2021092108144181600_CIT0051","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1176\/ajp.153.4.582b","article-title":"Possible antidepressant effect of minocycline","volume":"153","author":"Levine","year":"1996","journal-title":"Am J Psychiatry"},{"key":"2021092108144181600_CIT0052","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2007.03.080","article-title":"Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia","volume":"1154","author":"Levkovitz","year":"2007","journal-title":"Brain Res"},{"key":"2021092108144181600_CIT0053","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2021092108144181600_CIT0054","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neubiorev.2015.05.014","article-title":"Inflammation in schizophrenia: a question of balance","volume":"55","author":"Leza","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"2021092108144181600_CIT0056","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/scan\/nsp052","article-title":"Type I and Type II error concerns in fMRI research: re-balancing the scale","volume":"4","author":"Lieberman","year":"2009","journal-title":"Soc Cogn Affect Neurosci"},{"key":"2021092108144181600_CIT0057","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11920-019-1085-1","article-title":"Prenatal maternal stress and the cascade of risk to schizophrenia spectrum disorders in offspring","volume":"21","author":"Lipner","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"2021092108144181600_CIT0058","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr Res"},{"key":"2021092108144181600_CIT0059","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145711001775","article-title":"Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation","volume":"16","author":"MacDowell","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"2021092108144181600_CIT0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.12.025","article-title":"Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia","volume":"116","author":"MacDowell","year":"2017","journal-title":"Neuropharmacology"},{"key":"2021092108144181600_CIT0061","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.jcp.0000155818.29091.53","article-title":"Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone","volume":"25","author":"Massana","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"2021092108144181600_CIT0062","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2014.01.019","article-title":"Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia","volume":"38","author":"Mattei","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2021092108144181600_CIT0063","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrd.2016.28","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2021092108144181600_CIT0064","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/mp.2017.106","article-title":"Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls","volume":"23","author":"Moberget","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2021092108144181600_CIT0065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/cn5003368","article-title":"Neurodevelopmental animal models reveal the convergent role of neurotransmitter systems, inflammation, and oxidative stress as biomarkers of schizophrenia: implications for novel drug development","volume":"6","author":"Moller","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"2021092108144181600_CIT0066","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sby024","article-title":"Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations","volume":"44","author":"Muller","year":"2018","journal-title":"Schizophr Bull"},{"key":"2021092108144181600_CIT0067","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"Nunez","year":"2004","journal-title":"Synapse"},{"key":"2021092108144181600_CIT0068","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/mp.2015.209","article-title":"Abnormal asymmetries in subcortical brain volume in schizophrenia","volume":"21","author":"Okada","year":"2016","journal-title":"Mol Psychiatry"},{"key":"2021092108144181600_CIT0069","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2021092108144181600_CIT0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biopha.2007.12.005","article-title":"Does minocycline have antidepressant effect?","volume":"62","author":"Pae","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"2021092108144181600_CIT0071","volume-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2008","edition":"4th ed"},{"key":"2021092108144181600_CIT0072","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.biopsych.2011.06.007","article-title":"Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat","volume":"70","author":"Piontkewitz","year":"2011","journal-title":"Biol Psychiatry"},{"key":"2021092108144181600_CIT0073","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.neuropharm.2011.04.019","article-title":"Tracing the development of psychosis and its prevention: what can be learned from animal models","volume":"62","author":"Piontkewitz","year":"2012","journal-title":"Neuropharmacology"},{"key":"2021092108144181600_CIT0074","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13063-017-2275-y","article-title":"A randomised, double-blind, placebo-controlled trial of minocycline and\/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol","volume":"18","author":"Qurashi","year":"2017","journal-title":"Trials"},{"key":"2021092108144181600_CIT0075","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41398-017-0029-y","article-title":"Schizophrenia and depression, two poles of endocannabinoid system deregulation","volume":"7","author":"Rodriguez-Munoz","year":"2017","journal-title":"Transl Psychiatry"},{"key":"2021092108144181600_CIT0076","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.14642","article-title":"Minocycline in neurodegenerative and psychiatric diseases: an update","volume":"28","author":"Romero-Miguel","year":"2021","journal-title":"Eur J Neurol"},{"key":"2021092108144181600_CIT0077","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1523\/JNEUROSCI.5686-11.2012","article-title":"Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats","volume":"32","author":"Sakata","year":"2012","journal-title":"J Neurosci"},{"key":"2021092108144181600_CIT0078","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/14734220510008003","article-title":"Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function","volume":"4","author":"Sanchez-Perez","year":"2005","journal-title":"Cerebellum"},{"key":"2021092108144181600_CIT0079","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41583-019-0152-2","article-title":"Emerging connections between cerebellar development, behaviour and complex brain disorders","volume":"20","author":"Sathyanesan","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"2021092108144181600_CIT0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00406-009-0017-1","article-title":"Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia","volume":"260","author":"Schmitt","year":"2010","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2021092108144181600_CIT0081","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00124509-200603000-00017","article-title":"Increased thalamostriatal-mesiotemporal glucose uptake with symptom remission in schizophrenia\u2013a case report","volume":"22","author":"Seethalakshmi","year":"2006","journal-title":"J Ect"},{"key":"2021092108144181600_CIT0082","first-page":"624","article-title":"The laboratory rat: relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"key":"2021092108144181600_CIT0083","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archpsyc.57.11.1033","article-title":"Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging","volume":"57","author":"Shergill","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"2021092108144181600_CIT0084","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s11307-014-0753-0","article-title":"Response to deep brain stimulation in the lateral hypothalamic area in a rat model of obesity: in vivo assessment of brain glucose metabolism","volume":"16","author":"Soto-Montenegro","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"2021092108144181600_CIT0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.nicl.2013.12.007","article-title":"Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation","volume":"4","author":"Stegmayer","year":"2014","journal-title":"Neuroimage Clin"},{"key":"2021092108144181600_CIT0086","first-page":"397","article-title":"Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-\u03baB signaling pathways","volume":"4","author":"Sun","year":"2015","journal-title":"Biochem Biophys Rep"},{"key":"2021092108144181600_CIT0087","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1007\/s12035-020-02028-8","article-title":"Maternal immune activation causes schizophrenia-like behaviors in the offspring through activation of immune-inflammatory, oxidative and apoptotic pathways, and lowered antioxidant defenses and neuroprotection","volume":"57","author":"Talukdar","year":"2020","journal-title":"Mol Neurobiol"},{"key":"2021092108144181600_CIT0088","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archpsyc.1992.01820070016003","article-title":"Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome","volume":"49","author":"Tamminga","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"2021092108144181600_CIT0089","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s12035-015-9154-x","article-title":"Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2","volume":"53","author":"Tang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"2021092108144181600_CIT0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17705\/1CAIS.02804","article-title":"A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research","volume":"28","author":"Templeton","year":"2011","journal-title":"CAIS"},{"key":"2021092108144181600_CIT0091","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/ijmm.2017.2908","article-title":"Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2","volume":"39","author":"Tian","year":"2017","journal-title":"Int J Mol Med"},{"key":"2021092108144181600_CIT0092","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1352\/1944-7558-115.5.433","article-title":"Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures","volume":"115","author":"Utari","year":"2010","journal-title":"Am J Intellect Dev Disabil"},{"key":"2021092108144181600_CIT0093","first-page":"26","article-title":"An in vivo MRI template set for morphometry, tissue segmentation, and fMRI localization in rats","volume":"5","author":"Valdes-Hernandez","year":"2011","journal-title":"Front Neuroinform"},{"key":"2021092108144181600_CIT0094","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol Psychiatry"},{"key":"2021092108144181600_CIT0095","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbu069","article-title":"Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations","volume":"40","author":"van Os","year":"2014","journal-title":"Schizophr Bull"},{"key":"2021092108144181600_CIT0096","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nicl.2017.11.005","article-title":"Evaluation of factors influencing 18F-FET uptake in the brain","volume":"17","author":"Verger","year":"2018","journal-title":"Neuroimage Clin"},{"key":"2021092108144181600_CIT0097","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"2021092108144181600_CIT0098","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S1807-59322011001300009","article-title":"The role of the cerebellum in schizophrenia: from cognition to molecular pathways","volume":"66 Suppl 1","author":"Yeganeh-Doost","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"2021092108144181600_CIT0099","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/sj.npp.1301313","article-title":"Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine","volume":"32","author":"Zhang","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"2021092108144181600_CIT0100","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","article-title":"Profile of minocycline and its potential in the treatment of schizophrenia","volume":"10","author":"Zhang","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2021092108144181600_CIT0101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pnpbp.2018.04.004","article-title":"Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: association with pro-inflammatory cytokine levels","volume":"85","author":"Zhang","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021092108144181600_CIT0102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.schres.2019.08.005","article-title":"The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia","volume":"212","author":"Zhang","year":"2019","journal-title":"Schizophr Res"},{"key":"2021092108144181600_CIT0103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2017.12.017","article-title":"Structural and functional brain abnormalities in schizophrenia: a cross-sectional study at different stages of the disease","volume":"83","author":"Zhao","year":"2017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2021092108144181600_CIT0104","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0269881119858286","article-title":"Adjunctive minocycline for major mental disorders: a systematic review","volume":"33","author":"Zheng","year":"2019","journal-title":"J Psychopharmacol"},{"key":"2021092108144181600_CIT0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroscience.2013.10.023","article-title":"Peripheral immunomodulation with ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits in rats","volume":"256","author":"Zheng","year":"2014","journal-title":"Neuroscience"},{"key":"2021092108144181600_CIT0106","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.psychres.2014.06.046","article-title":"Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid","volume":"219","author":"Zhu","year":"2014","journal-title":"Psychiatry Res"},{"key":"2021092108144181600_CIT0107","doi-asserted-by":"crossref","first-page":"e93966","DOI":"10.1371\/journal.pone.0093966","article-title":"Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"2021092108144181600_CIT0108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00213-003-1461-7","article-title":"Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation","volume":"169","author":"Zuckerman","year":"2003","journal-title":"Psychopharmacology"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyab036\/39306094\/pyab036.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/9\/734\/40418741\/pyab036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/24\/9\/734\/40418741\/pyab036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T04:22:59Z","timestamp":1632198179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/24\/9\/734\/6308934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":107,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,6,24]]},"published-print":{"date-parts":[[2021,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyab036","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,6,24]]}}}